Swedish Orphan Biovitrum AB (publ) (SOBI.ST)
Stockholm - Stockholm Real-time price. Currency in SEK
Add to watchlist
At close: 05:29PM CEST
| Previous close | 213.00 |
| Open | 211.70 |
| Bid | 212.50 x 0 |
| Ask | 213.40 x 0 |
| Day's range | 210.50 - 215.10 |
| 52-week range | 139.55 - 245.40 |
| Volume | |
| Avg. volume | 597,011 |
| Market cap | 62.278B |
| Beta (5Y monthly) | 0.49 |
| PE ratio (TTM) | 24.74 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Apellis (APLS) Hit By Wider-Than-Expected Q1 Loss, Revenues Top
Apellis' (APLS) earnings missed estimates in the first quarter of 2022, while revenues surpassed expectations.
- Zacks
Apellis (APLS) Q4 Loss Widens, Revenues Surpass Estimates
Apellis' (APLS) earnings miss estimates in the fourth quarter of 2021, while revenues surpass expectations.
- Zacks
Apellis (APLS), Sobi Get EU Nod for Rare Blood Disorder Drug
The European Commission approves Apellis (APLS) and Sobi's Aspaveli for the treatment of paroxysmal nocturnal hemoglobinuria in adult patients. Shares rise.
© 2022 Yahoo. All rights reserved.
